• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Can Africa achieve herd immunity?非洲能否实现群体免疫?
Glob Health Res Policy. 2021 Dec 2;6(1):46. doi: 10.1186/s41256-021-00231-1.
2
Overcoming COVID-19 in West African countries: is herd immunity an option?西非国家战胜新冠疫情:群体免疫是一种选择吗?
Pan Afr Med J. 2020 Jul 6;35(Suppl 2):103. doi: 10.11604/pamj.supp.2020.35.2.24217. eCollection 2020.
3
R of COVID-19 and its impact on vaccination coverage: compared with previous outbreaks.COVID-19 的 R 值及其对疫苗接种率的影响:与以往疫情相比。
Hum Vaccin Immunother. 2021 Nov 2;17(11):3850-3854. doi: 10.1080/21645515.2020.1865046. Epub 2021 Oct 6.
4
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
5
SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.津巴布韦的 SARS-CoV-2:迈向预期 60%群体免疫所面临的里程碑和挑战。
Pan Afr Med J. 2021 Aug 20;39:255. doi: 10.11604/pamj.2021.39.255.30331. eCollection 2021.
6
A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists.对巴基斯坦药剂师的认知和对 COVID-19 疫苗犹豫的定性洞察。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2031455. doi: 10.1080/21645515.2022.2031455. Epub 2022 Feb 22.
7
Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?新冠疫情时代的疫苗犹豫:过去的经验能否帮助预测未来?
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-3. doi: 10.1080/21645515.2021.1893062. Epub 2021 Mar 8.
8
SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.SARS-CoV-2 变体和疫苗接种率在 Delta 变体出现期间面临的全球大流行:一项旨在寻找疫苗犹豫原因的全国性调查。
J Infect Public Health. 2022 Jul;15(7):773-780. doi: 10.1016/j.jiph.2022.06.007. Epub 2022 Jun 17.
9
Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.建模澳大利亚针对 SARS-CoV-2 Delta 变异株的疫苗接种对直接和群体保护的效果。
Med J Aust. 2021 Nov 1;215(9):427-432. doi: 10.5694/mja2.51263. Epub 2021 Oct 11.
10
Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.在澳大利亚新南威尔士州疫苗供应有限和充足的情况下,对 COVID-19 疫苗接种策略和群体免疫的建模。
Vaccine. 2022 Apr 14;40(17):2506-2513. doi: 10.1016/j.vaccine.2021.04.042. Epub 2021 Apr 24.

引用本文的文献

1
Achieving COVID-19 herd immunity in Algeria: Current state of vaccination, challenges, and recommendations.阿尔及利亚实现新冠病毒群体免疫:疫苗接种现状、挑战与建议
Public Health Chall. 2023 Mar 17;2(1):e76. doi: 10.1002/puh2.76. eCollection 2023 Mar.
2
Towards a post-COVID world: Challenges and progress of recovery in Kazakhstan.迈向新冠后时代:哈萨克斯坦的复苏挑战与进展
Public Health Chall. 2022 Sep 2;1(3):e17. doi: 10.1002/puh2.17. eCollection 2022 Sep.
3
Will Cape Verde attain COVID-19 herd immunity? Progress, Challenges, and Recommendations.佛得角能否实现新冠病毒群体免疫?进展、挑战与建议。
Public Health Chall. 2023 Jul 12;2(3):e103. doi: 10.1002/puh2.103. eCollection 2023 Sep.
4
Achieving COVID-19 herd immunity in Ethiopia.在埃塞俄比亚实现新冠病毒群体免疫。
Public Health Chall. 2023 Jun 19;2(2):e99. doi: 10.1002/puh2.99. eCollection 2023 Jun.
5
COVID-19 vaccination intention among internally displaced persons in complex humanitarian emergency context, Northeast Nigeria.在复杂人道主义紧急情况下,尼日利亚东北部境内流离失所者的 COVID-19 疫苗接种意愿。
PLoS One. 2024 Aug 30;19(8):e0308139. doi: 10.1371/journal.pone.0308139. eCollection 2024.
6
Public Health Emergence: Challenges and Prospects for the Future of Herd Immunity to Reduce the Negative Impact of Disease X in Low- and Middle-Income Countries.突发公共卫生事件:群体免疫在低收入和中等收入国家降低疾病X负面影响的未来挑战与前景
Clin Pathol. 2024 May 14;17:2632010X241254961. doi: 10.1177/2632010X241254961. eCollection 2024 Jan-Dec.
7
Four Years Since COVID-19 Day Zero: A Time to Evaluate Past and Future Pandemic Control Policies and Practices in Sub-Saharan Africa?自新冠疫情零日起四年:是评估撒哈拉以南非洲过去和未来大流行控制政策与实践的时候了?
Risk Manag Healthc Policy. 2024 Mar 5;17:505-511. doi: 10.2147/RMHP.S449701. eCollection 2024.
8
Road to achieving COVID-19 herd immunity in Niger Republic: Challenges and recommendations.尼日尔共和国实现新冠病毒群体免疫之路:挑战与建议
Public Health Chall. 2022 Dec;1(4):e38. doi: 10.1002/puh2.38. Epub 2022 Dec 7.
9
Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity.严重急性呼吸综合征冠状病毒2减毒活疫苗的间接传播及其对群体免疫的贡献。
Vaccines (Basel). 2023 Mar 14;11(3):655. doi: 10.3390/vaccines11030655.
10
Achieving herd immunity in South America.在南美洲实现群体免疫。
Glob Health Res Policy. 2023 Feb 1;8(1):2. doi: 10.1186/s41256-023-00286-2.

本文引用的文献

1
Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives.COVID-19 大流行对医疗保健设施和系统的经济影响:国际视角。
Best Pract Res Clin Anaesthesiol. 2021 Oct;35(3):293-306. doi: 10.1016/j.bpa.2020.11.009. Epub 2020 Nov 17.
2
Risk communication and community engagement strategies for COVID-19 in 13 African countries.13个非洲国家针对新冠疫情的风险沟通与社区参与策略
Health Promot Perspect. 2021 May 19;11(2):137-147. doi: 10.34172/hpp.2021.18. eCollection 2021.
3
Equitable and Effective Distribution of the COVID-19 Vaccines - A Scientific and Moral Obligation.公平有效分配新冠疫苗:科学与道德的责任。
Int J Health Policy Manag. 2022 Feb 1;11(2):100-102. doi: 10.34172/ijhpm.2021.49.
4
'Unprecedented achievement': who received the first billion COVID vaccinations?“史无前例的成就”:谁接种了首批10亿剂新冠疫苗?
Nature. 2021 Apr 29. doi: 10.1038/d41586-021-01136-2.
5
While flattening the curve and raising the line, Africa should not forget street vending practices.在努力实现曲线平缓并提升基准线的同时,非洲不应忽视街头小贩的经营活动。
Health Promot Perspect. 2021 Feb 7;11(1):32-35. doi: 10.34172/hpp.2021.05. eCollection 2021.
6
Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context.应对非洲的疫苗犹豫:预期的 COVID-19 疫苗背景。
Pan Afr Med J. 2021 Jan 5;38:3. doi: 10.11604/pamj.2021.38.3.27401. eCollection 2021.
7
Who Will Pay for the COVID-19 Vaccines for Africa?非洲的 COVID-19 疫苗将由谁来买单?
Am J Trop Med Hyg. 2021 Jan 7;104(3):794-796. doi: 10.4269/ajtmh.20-1506.
8
Non-viral COVID-19 vaccine delivery systems.非病毒 COVID-19 疫苗传递系统。
Adv Drug Deliv Rev. 2021 Feb;169:137-151. doi: 10.1016/j.addr.2020.12.008. Epub 2020 Dec 17.
9
Overcoming COVID-19 in West African countries: is herd immunity an option?西非国家战胜新冠疫情:群体免疫是一种选择吗?
Pan Afr Med J. 2020 Jul 6;35(Suppl 2):103. doi: 10.11604/pamj.supp.2020.35.2.24217. eCollection 2020.
10
The coronavirus is mutating - does it matter?新冠病毒正在变异——这有关系吗?
Nature. 2020 Sep;585(7824):174-177. doi: 10.1038/d41586-020-02544-6.

非洲能否实现群体免疫?

Can Africa achieve herd immunity?

机构信息

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.

Faculty of Management and Development Studies, University of the Philippines Open University, Los Baños, Laguna, Philippines.

出版信息

Glob Health Res Policy. 2021 Dec 2;6(1):46. doi: 10.1186/s41256-021-00231-1.

DOI:10.1186/s41256-021-00231-1
PMID:34852844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8636285/
Abstract

The World Health Organization described herd immunity, also known as population immunity, as the indirect fortification from an infectious disease that happens when a population is immune either through vaccination or immunity developed through previous exposure to infection. The emergence of COVID-19 vaccine is a step towards the achievement of herd immunity. Over one billion people across the globe have been vaccinated and Africa recorded only 2%. The objective of this article was to develop a forecast of the number of people to be vaccinated to achieve herd immunity in the 13 WHO-identified priority African countries for COVID-19. Herd immunity is achieved when one infected person in a population causes less than one secondary case on average, corresponding to the effective basic reproduction number (R). Vaccine delivery and distribution infrastructure including the cold chain remains weak. Vaccine hesitancy is also one of the limiting factors that may hinder herd immunity in Africa. In order to achieve herd immunity globally, African countries should not be excluded in fair and equal distribution of vaccines. Relevant stakeholders should foster commitment as well as community sensitization on COVID-19 vaccines and integration of COVID-19 vaccines in existing healthcare services.

摘要

世界卫生组织将群体免疫(也称为人群免疫)描述为一种间接防御传染病的方式,当人群通过接种疫苗或以前接触感染而产生免疫力时,就会发生这种情况。COVID-19 疫苗的出现是实现群体免疫的一步。全球已有超过 10 亿人接种了疫苗,而非洲仅记录了 2%。本文的目的是预测在世界卫生组织确定的 COVID-19 优先非洲国家中,为实现群体免疫而需要接种疫苗的人数。当人群中一个感染者平均导致不到一个二次病例时,就会达到群体免疫,这对应于有效基本繁殖数 (R)。疫苗的提供和分配基础设施,包括冷链,仍然薄弱。疫苗犹豫也是可能阻碍非洲群体免疫的限制因素之一。为了在全球范围内实现群体免疫,非洲国家不应被排除在公平和公平分配疫苗之外。相关利益攸关方应促进对 COVID-19 疫苗的承诺以及社区宣传,并将 COVID-19 疫苗纳入现有医疗保健服务中。